» Articles » PMID: 15576463

Activation of the Mammalian Target of Rapamycin Pathway Acutely Inhibits Insulin Signaling to Akt and Glucose Transport in 3T3-L1 and Human Adipocytes

Overview
Journal Endocrinology
Specialty Endocrinology
Date 2004 Dec 4
PMID 15576463
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

The mammalian target of rapamycin (mTOR) pathway has recently emerged as a chronic modulator of insulin-mediated glucose metabolism. In this study, we evaluated the involvement of this pathway in the acute regulation of insulin action in both 3T3-L1 and human adipocytes. Insulin rapidly (t(1/2) = 5 min) stimulated the mTOR pathway, as reflected by a 10-fold stimulation of 70-kDa ribosomal S6 kinase 1 (S6K1) activity in 3T3-L1 adipocytes. Inhibition of mTOR/S6K1 by rapamycin increased insulin-stimulated glucose transport by as much as 45% in 3T3-L1 adipocytes. Activation of mTOR/S6K1 by insulin was associated with a rapamycin-sensitive increase in Ser636/639 phosphorylation of insulin receptor substrate (IRS)-1 but, surprisingly, did not result in impaired IRS-1-associated phosphatidylinositol (PI) 3-kinase activity. However, insulin-induced activation of Akt was increased by rapamycin. Insulin also activated S6K1 and increased phosphorylation of IRS-1 on Ser636/639 in human adipocytes. As in murine cells, rapamycin treatment of human adipocytes inhibited S6K1, blunted Ser636/639 phosphorylation of IRS-1, leading to increased Akt activation and glucose uptake by insulin. Further studies in 3T3-L1 adipocytes revealed that rapamycin prevented the relocalization of IRS-1 from the low-density membranes to the cytosol in response to insulin. Furthermore, inhibition of mTOR markedly potentiated the ability of insulin to increase PI 3,4,5-triphosphate levels concomitantly with an increased phosphorylation of Akt at the plasma membrane, low-density membranes, and cytosol. However, neither GLUT4 nor GLUT1 translocation induced by insulin were increased by rapamycin treatment. Taken together, these results indicate that the mTOR pathway is an important modulator of the signals involved in the acute regulation of insulin-stimulated glucose transport in 3T3-L1 and human adipocytes.

Citing Articles

Kinetic modeling of leucine-mediated signaling and protein metabolism in human skeletal muscle.

McColl T, Clarke D iScience. 2024; 27(1):108634.

PMID: 38188514 PMC: 10767222. DOI: 10.1016/j.isci.2023.108634.


Queueing theory model of mTOR complexes' impact on Akt-mediated adipocytes response to insulin.

Kloska S, Palczynski K, Marciniak T, Talaska T, Miller M, Wysocki B PLoS One. 2022; 17(12):e0279573.

PMID: 36574435 PMC: 9794039. DOI: 10.1371/journal.pone.0279573.


The Novel Peptide Chm-273s Has Therapeutic Potential for Metabolic Disorders: Evidence from In Vitro Studies and High-Sucrose Diet and High-Fat Diet Rodent Models.

Mitkin N, Pavshintcev V, Sukhanova I, Doronin I, Babkin G, Sadagurski M Pharmaceutics. 2022; 14(10).

PMID: 36297523 PMC: 9611607. DOI: 10.3390/pharmaceutics14102088.


Sexual dimorphism in the molecular mechanisms of insulin resistance during a critical developmental window in Wistar rats.

Ortiz-Huidobro R, Larque C, Velasco M, Chavez-Maldonado J, Sabido J, Sanchez-Zamora Y Cell Commun Signal. 2022; 20(1):154.

PMID: 36224569 PMC: 9554987. DOI: 10.1186/s12964-022-00965-6.


Normalization of maternal adiponectin in obese pregnant mice prevents programming of impaired glucose metabolism in adult offspring.

Dumolt J, Powell T, Jansson T, Rosario F FASEB J. 2022; 36(7):e22383.

PMID: 35670755 PMC: 9202510. DOI: 10.1096/fj.202200326R.